Profile
Stanley Iyadurai worked as Director-Neuromuscular Genetics Clinic at The Ohio State University.
From 2017 to 2018, worked as Director-Clinical Research & Development at CSL Behring LLC.
From 2018 to 2025, worked as Senior VP-Medical Affairs & Drug Discovery at Catalyst Pharmaceuticals, Inc. Education includes a doctorate from the University of Minnesota.
Former positions of Stanley Iyadurai
| Companies | Position | End |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2025-12-01 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Corporate Officer/Principal | 2018-06-30 |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Stanley Iyadurai
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets novel medicines for patients living with rare diseases | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
- Stock Market
- Insiders
- Stanley Iyadurai
















